Cargando…

Unfavorable Outcomes Related to Endovascular Treatment of Giant Vertebrobasilar Aneurysms

Background: Giant vertebrobasilar aneurysms (GVBAs) have an unfavorable natural history if left untreated and often pose a sizeable challenge to endovascular treatment. The aim of this study was to analyze the angiographic and clinical outcomes of GVBAs treated by various endovascular procedures. Me...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Miao, Liang, Huaxin, Wang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431816/
https://www.ncbi.nlm.nih.gov/pubmed/32849210
http://dx.doi.org/10.3389/fneur.2020.00748
_version_ 1783571657528442880
author Li, Miao
Liang, Huaxin
Wang, Jie
author_facet Li, Miao
Liang, Huaxin
Wang, Jie
author_sort Li, Miao
collection PubMed
description Background: Giant vertebrobasilar aneurysms (GVBAs) have an unfavorable natural history if left untreated and often pose a sizeable challenge to endovascular treatment. The aim of this study was to analyze the angiographic and clinical outcomes of GVBAs treated by various endovascular procedures. Methods: Between January 2010 and September 2018, 27 patients with 27 GVBAs treated endovascularly were enrolled in this consecutive study. The clinical and angiographic features, treatment modalities, and outcomes were analyzed. Results: The patient cohort comprised 21 men (77.8%) and 6 women (22.2%) of mean age 42.7 ± 18.9 years (range, 6–65 years). The most common presenting symptom was compressive symptoms, present in 15 patients (55.6%). None of the GVBAs was ruptured. Of the 27 GVBAs, 23 aneurysms were dissecting aneurysm with intramural hematoma and 4 aneurysms were saccular. Regarding treatment approach, internal trapping was used in 5 aneurysms, stent-assisted coil embolization in 10, sole stenting in 4, and flow diverters in 8. Overall, 12 patients (44.4%) had an unfavorable angiographic or clinical outcome: 3 patients presented with post-operative complications and subsequent death, and 9 with poor prognosis during follow-up. Conclusions: Patients with GVBAs may not benefit from endovascular treatment. Newer-generation devices are necessary to provide more optimal therapy for the management of these complex lesions.
format Online
Article
Text
id pubmed-7431816
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-74318162020-08-25 Unfavorable Outcomes Related to Endovascular Treatment of Giant Vertebrobasilar Aneurysms Li, Miao Liang, Huaxin Wang, Jie Front Neurol Neurology Background: Giant vertebrobasilar aneurysms (GVBAs) have an unfavorable natural history if left untreated and often pose a sizeable challenge to endovascular treatment. The aim of this study was to analyze the angiographic and clinical outcomes of GVBAs treated by various endovascular procedures. Methods: Between January 2010 and September 2018, 27 patients with 27 GVBAs treated endovascularly were enrolled in this consecutive study. The clinical and angiographic features, treatment modalities, and outcomes were analyzed. Results: The patient cohort comprised 21 men (77.8%) and 6 women (22.2%) of mean age 42.7 ± 18.9 years (range, 6–65 years). The most common presenting symptom was compressive symptoms, present in 15 patients (55.6%). None of the GVBAs was ruptured. Of the 27 GVBAs, 23 aneurysms were dissecting aneurysm with intramural hematoma and 4 aneurysms were saccular. Regarding treatment approach, internal trapping was used in 5 aneurysms, stent-assisted coil embolization in 10, sole stenting in 4, and flow diverters in 8. Overall, 12 patients (44.4%) had an unfavorable angiographic or clinical outcome: 3 patients presented with post-operative complications and subsequent death, and 9 with poor prognosis during follow-up. Conclusions: Patients with GVBAs may not benefit from endovascular treatment. Newer-generation devices are necessary to provide more optimal therapy for the management of these complex lesions. Frontiers Media S.A. 2020-08-11 /pmc/articles/PMC7431816/ /pubmed/32849210 http://dx.doi.org/10.3389/fneur.2020.00748 Text en Copyright © 2020 Li, Liang and Wang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Li, Miao
Liang, Huaxin
Wang, Jie
Unfavorable Outcomes Related to Endovascular Treatment of Giant Vertebrobasilar Aneurysms
title Unfavorable Outcomes Related to Endovascular Treatment of Giant Vertebrobasilar Aneurysms
title_full Unfavorable Outcomes Related to Endovascular Treatment of Giant Vertebrobasilar Aneurysms
title_fullStr Unfavorable Outcomes Related to Endovascular Treatment of Giant Vertebrobasilar Aneurysms
title_full_unstemmed Unfavorable Outcomes Related to Endovascular Treatment of Giant Vertebrobasilar Aneurysms
title_short Unfavorable Outcomes Related to Endovascular Treatment of Giant Vertebrobasilar Aneurysms
title_sort unfavorable outcomes related to endovascular treatment of giant vertebrobasilar aneurysms
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431816/
https://www.ncbi.nlm.nih.gov/pubmed/32849210
http://dx.doi.org/10.3389/fneur.2020.00748
work_keys_str_mv AT limiao unfavorableoutcomesrelatedtoendovasculartreatmentofgiantvertebrobasilaraneurysms
AT lianghuaxin unfavorableoutcomesrelatedtoendovasculartreatmentofgiantvertebrobasilaraneurysms
AT wangjie unfavorableoutcomesrelatedtoendovasculartreatmentofgiantvertebrobasilaraneurysms